Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-22 Godshall Douglas Evan Director Grant or award · Stock Option (Right to Buy) +11,000 11,000
2021-06-22 GUYER DAVID R Director Grant or award · Restricted Stock Units +2,500 2,500
2021-06-22 GUYER DAVID R Director Grant or award · Stock Option (Right to Buy) +11,000 11,000
2021-06-22 Landis John B. Director Grant or award · Restricted Stock Units +2,500 2,500
2021-06-22 Landis John B. Director Grant or award · Stock Option (Right to Buy) +11,000 11,000
2021-06-22 DICICCO WENDY F Director Grant or award · Restricted Stock Units +2,500 2,500
2021-06-22 DICICCO WENDY F Director Grant or award · Stock Option (Right to Buy) +11,000 11,000
2021-06-22 ANDO GORAN Director Grant or award · Restricted Stock Units +2,750 2,750
2021-06-22 ANDO GORAN Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2021-06-22 Paggiarino Dario A. Chief Medical Officer Grant or award · Restricted Stock Units +14,900 14,900
2021-06-22 Paggiarino Dario A. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +60,300 60,300
2021-06-22 Jones David Scott SVP & Chief Commercial Officer Grant or award · Restricted Stock Units +14,900 19,005
2021-06-22 Jones David Scott SVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +60,300 60,300
2021-06-22 Elston George Chief Financial Officer Grant or award · Restricted Stock Units +14,900 14,900
2021-06-22 Elston George Chief Financial Officer Grant or award · Stock Option (Right to Buy) +60,300 60,300
2021-06-22 Lurker Nancy President & CEO Grant or award · Restricted Stock Units +52,600 52,600
2021-06-22 Lurker Nancy President & CEO Grant or award · Stock Option (Right to Buy) +213,700 213,700
2021-06-14 Lurker Nancy President & CEO Option exercise +4,500 113,546
2021-06-14 Lurker Nancy President & CEO Option exercise · Restricted Stock Units −4,500 0
2021-06-14 Paggiarino Dario A. Chief Medical Officer Option exercise +1,420 13,012

Page 30 of 31 · 616 trades